Agreement signedPublished 31 Mar 2026

Lifeward Ltd. /
Oratech Pharma, Inc.

Lifeward Ltd. agrees to buy Oratech Pharma, Inc.

Buy side: Lifeward Ltd.
Buy sideLifeward Ltd.
Target: Oratech Pharma, Inc.
TargetOratech Pharma, Inc.
Oramed Pharmaceuticals Inc. · 31 Mar 2026Source
Buy side: Lifeward Ltd.
Buy sideLifeward Ltd.
Target: Oratech Pharma, Inc.
TargetOratech Pharma, Inc.
01 / BuyerLifeward Ltd.
02 / TargetOratech Pharma, Inc.
Source for the buyer and target: Oramed Pharmaceuticals Inc.

For the buyer and target.

“As previously reported in a Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on January 14, 2026 (the “Prior 8-K”), on January 12, 2026, Oramed Pharmaceuticals Inc. (the “Company”) entered into that certain Share Purchase Agreement (“Share Purchase Agreement”), by and among the Company, Lifeward Ltd. (“Lifeward”) and Oratech Pharma, Inc., the Company’s wholly-owned subsidiary (“Oratech”).”

Published 31 Mar 2026

Open the source
01

What happened

Lifeward Ltd. agreed to acquire Oratech Pharma, Inc., according to a filing dated March 31, 2026. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Oramed Pharmaceuticals Inc.

Lifeward Ltd. agrees to buy Oratech Pharma, Inc.

This document is the source for the companies, stage and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    “Lifeward Ltd. agrees to buy Oratech Pharma, Inc. Lifeward Ltd. agreed to acquire Oratech Pharma, Inc., according to a filing dated March 31, 2026”

    Open the source
  2. Published by Oramed Pharmaceuticals Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.